EX-23.1 5 rvnc1231201410kex231.htm EXHIBIT 23.1 RVNC 12.31.2014 10K EX23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S‑8 (Nos. 333- 193963 and 333-198499) of Revance Therapeutics Inc. of our report dated March 4, 2015 relating to the financial statements, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP
San Jose, California
March 4, 2015